Core Laboratories Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $161.0M | $17.7M |
| FY2022 | $172.4M | $184.3M | $15.4M |
| FY2023 | $163.1M | $224.8M | $15.1M |
| FY2024 | $126.1M | $246.6M | $19.2M |
| FY2025 | $110.3M | $266.0M | $22.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $161.0M | $17.7M |
| FY2022 | $172.4M | $184.3M | $15.4M |
| FY2023 | $163.1M | $224.8M | $15.1M |
| FY2024 | $126.1M | $246.6M | $19.2M |
| FY2025 | $110.3M | $266.0M | $22.7M |